Determination of asymmetric dimethyl arginine in human serum by liquid chromatography-tandem mass spectrometry: Clinical application in hypertensive subjects

Clinical Chemistry and Laboratory Medicine

Volumn 49, Issue 12, 2011, Pages 2109-2115

  Gervasoni, Jacopo ^a   Bonelli, Fabio ^b   Zuppi, Cecilia ^a   Zappacosta, Bruno ^c   Mordente, Alvaro ^a   Calvani, Riccardo ^a   Persichilli, Silvia ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b MS Partners SRL Via Savoia   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

Author keywords

Asymmetric dimethylarginine; Hydrophilic interaction chromatography; Hypertension; Liquid chromatography tandem mass spectrometry

Indexed keywords

6 N,N' DIMETHYLARGININE; AMMONIUM FORMATE; CREATININE; FORMIC ACID; GLUCOSE; N(G),N(G) DIMETHYLARGININE;

ACCURACY; ADULT; ARTICLE; BIOLOGICAL MONITORING; BLOOD SAMPLING; BODY MASS; CHEMICAL REACTION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ESSENTIAL HYPERTENSION; FEMALE; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYDROPHILICITY; HYPERTENSION; LIQUID CHROMATOGRAPHY; MALE; MOLECULAR WEIGHT; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY ANALYSIS; TANDEM MASS SPECTROMETRY; VALIDATION STUDY; WAIST CIRCUMFERENCE;

ADOLESCENT; ADULT; ARGININE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; HYPERTENSION; MALE; MIDDLE AGED; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

EID: 84856511179     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2011.691     Document Type: Article

References (42)

1. Gary JD, Clarke S. RNA and protein interactions modulated by protein arginine methylation. Prog Nucleic Acid Res Mol Biol 1998;61:65-131.
2. Boisvert FM, Coté J, Boulanger MC, Richard S. A proteomic analysis of arginine-methylated protein complexes. Mol Cell Proteomics 2003;2:1319-30.
3. Bachand F, Silver PA. PRMT3 is a ribosomal protein methyltransferase that affects the cellular levels of ribosomal subunits. EMBO J 2004;23:2641-50. (Pubitemid 38988235)
4. Kimoto M, Tsuji H, Ogawa T, Sasaoka K. Detection of NG, NG-dimethylarginine dimethylaminohydrolase in the nitric oxide-generating systems of rats using monoclonal antibody. Arch Biochem Biophys 1993;300:657-62. (Pubitemid 23232925)
5. Tran CT, Fox MF, Vallance P, Leiper JM. Chromosomal localization, gene structure, and expression pattern of DDAH1: Comparison with DDAH2 and implications for evolutionary origins. Genomics 2000;68:101-5.
6. Leiper JM, Santa Maria J, Chubb A, MacAllister RJ, Charles IG, Whitley GS, et al. Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases. Biochem J 1999;343:209-14.
7. Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992;339:572-5.
8. Boger RH, Lentz SR, Bode-Boger SM, Knapp HR, Haynes WG. Elevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst(e)-inaemia in humans. Clin Sci 2001;100:161-7. (Pubitemid 32165360)
9. Ohike Y, Kozaki K, Iijima K, Eto M, Kojima T, Ohga E, et al. Amelioration of vascular endothelial dysfunction in obstructive sleep apnea syndrome by nasal continuous positive airway pressure. Possible involvement of nitric oxide and asymmetric NG, NG-dimethylarginine. Circ J 2005;69:221-6. (Pubitemid 40313045)
10. Perticone F, Sciacqua A, Maio R, Perticone M, Maas R, Boger RH, et al. Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension. J Am Coll Cardiol 2005;46:518-23. (Pubitemid 41040296)
11. Anderssohn M, Schwedhelm E, Lüneburg N, Vasan RS, Böger RH. Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: An intriguing interaction with diabetes mellitus. Diab Vasc Dis Res 2010;7:105-18.
12. Böger RH. Asymmetric dimethylarginine (ADMA) and cardiovascular disease: Insights from prospective clinical trials. Vasc Med 2005;10:19-25.
13. Böger RH, Diemert A, Schwedhelm E, Lüneburg N, Maas R, Hecher K. The role of nitric oxide synthase inhibition by asymmetric dimethylarginine in the pathophysiology of preeclampsia Gynecol Obstet Invest 2010;69:1-13.
14. Nijveldt RJ, Teerlink T, van der Hoven B, Siroen MP, Kuik DJ, Rauwerda JA, et al. Asymmetrical dimethylarginine (ADMA) in critically ill patients: High plasma ADMA concentration is an independent risk factor of ICU mortality. Clin Nutr 2003; 22:23-30. (Pubitemid 36193177)
15. Tsikas D. A critical review and discussion of analytical methods in the L-arginine/nitric oxide area of basic and clinical research. Anal Biochem 2008;379:139-63.
16. Schwedhelm E. Quantification of ADMA: Analytical approaches. Vascular Medicine 2005;10:S89-95. (Pubitemid 43137272)
17. Teerlink T. HPLC analysis of ADMA and other methylated larginine analogs in biological fluids. J Chromatogr B 2007; 851:21-9. (Pubitemid 46720132)
18. Pettersson A, Uggla L, Backman V. Determination of dimethylated arginines in human plasma by high performance liquid chromatography. J Chromatogr B 1997;692:257-62. (Pubitemid 27217827)
19. Tsikas D, Junker W, Frolich JC. Determination of dimethylated arginines in human plasma by high-performance liquid chromatography. J Chromatogr B 1998;705:174-6. (Pubitemid 28045673)
20. Ivanova M, Artusi C, Boffa GM, Zaninotto M, Plebani M. HPLC determination of plasma dimethylarginines: Method validation and preliminary clinical application. Clin Chim Acta 2010;411:1632-6.
21. Chen BM, Xia LW, Liang SX, Chen GH, Deng FL, Zhang WR, et al. Simultaneous determination of L-arginine and dimethylarginines in human urine by high-performance liquid chromatography. Anal Chim Acta 2001;444:223-7.
22. Teerlink T, Nijveldt RJ, de Jong S, van Leeuwen PA. Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography. Anal Biochem 2002;303:131-7. (Pubitemid 34407576)
23. Zhang WZ, Kaye DM. Simultaneous determination of arginine and seven metabolites in plasma by reversed phase liquid chromatography with a time-controlled ortho-phthaldialdehyde precolumn derivatization. Anal Biochem 2004;326:87-92. (Pubitemid 38177486)
24. Teerlink T. Determination of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine in biological samples by HPLC. Methods Mol Med 2005;108:263-74.
25. Teerlink T. HPLC analysis of ADMA and other methylated larginine analogs in biological fluids. J Chromatogr B 2007; 851:21-9. (Pubitemid 46720132)
26. Di Gangi IM, Chiandetti L, Gucciardi A, Moret V, Naturale M, Giordano G. Simultaneous quantitative determination of N(G), N(G)-dimethyl-L-arginine or asymmetric dimethylarginine and related pathway's metabolites in biological fluids by ultrahighperformance liquid chromatography/electrospray ionizationtandem mass spectrometry. Anal Chim Acta 2010;16:140-8.
27. Martens-Lobenhoffer J, Bode-Boger SM. Simultaneous detection of arginine, asymmetric dimethylarginine, symmetric dime-thylarginine and citrulline in human plasma and urine applying liquid chromatography-mass spectrometry with very straightforward sample preparation. J Chromatogr B 2003;798:231-9. (Pubitemid 37487722)
28. Martens-Lobenhoffer J, Bode-Böger SM. Chromatographicmass spectrometric methods for the quantification of L-arginine and its methylated metabolites in biological fluids. J Chromatogr B 2007;851:30-41. (Pubitemid 46720133)
29. Schwedhelm E, Maas R, Tan-Andresen J, Schulze F, Riederer U, Böger RH. High-throughput liquid chromatographic-tandem mass spectrometric determination of arginine and dimethylated arginine derivatives in human and mouse plasma. J Chromatogr B 2007;851:211-9. (Pubitemid 46720141)
30. D'Apolito O, Paglia G, Tricarico F, Garofalo D, Pilotti A, Lamacchia O, et al. Development and validation of a fast quantitative method for plasma dimethylarginines analysis using liquid chromatography-tandem mass spectrometry. Clin Biochem 2008;41:1391-5.
31. Martens-Lobenhoffer J, Bode-Böger SM. Fast and efficient determination of arginine, symmetric dimethylarginine, and asymmetric dimethylarginine in biological fluids by hydrophilicinteraction liquid chromatography-electrospray tandem mass spectrometry. Clin Chem 2006;52:488-93.
32. Brown CM, Becker JO, Wise PM, Hoofnagle AN. Simultaneous determination of L-arginine metabolites in human and mouse plasma by using hydrophilic- interaction chromatography and electrospray tandem mass spectrometry. Clin Chem 2011; 57:701-9.
33. Schulze F, Wesemann R, Schwedhelm E, Sydow K, Albsmeier J, Cooke JP, et al. Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay. Clin Chem Lab Med 2004;42:1377-83. (Pubitemid 40057825)
34. Martens-Lobenhoffer J, Westphal S, Awiszus F, Bode-Böger SM, Luley C. Determination of asymmetric dimethylarginine: Liquid chromatography-mass spectrometry or ELISA? Clin Chem 2005;51:2188-9. (Pubitemid 41532646)
35. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of high blood pressure: The JNC 7 report. J Am Med Assoc 2003;21:2560-72. Erratum in: J Am Med Assoc 2003; 9:197. (Pubitemid 37430158)
36. Matuszewski BK, Constanzer ML, Chavez-Eng CM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal Chem 2003;13:3019-30. (Pubitemid 36830428)
37. Bonfiglio R, King RC, Olah TV, Merkle K. The effects of sample preparation methods on the variability of the electrospray ionization response for model drug compounds. Rapid Commun Mass Spectrom 1999;12:1175-85. (Pubitemid 29285118)
38. National Committee for Clinical Laboratory Standards. Protocols for determination of limits of detection and limits of quantitation; approved guideline. NCCLS document EP17-A. Wayne, PA: NCCLS, 2004.
39. National Committee for Clinical Laboratory Standards. Evaluation of precision performance of quantitative measurement methods; approved guideline. Second Edition. NCCLS document EP5-A2. Wayne, PA: NCCLS, 2004.
40. Paglia G, D'Apolito O, Tricarico F, Garofalo D, Corso G. Evaluation of mobile phase, ion pairing, and temperature influence on an HILIC-MS/MS method for L-arginine and its dimethylated derivatives detection. J Sep Sci 2008;31:2424-9.
41. Teerlink T. Measurement of asymmetric dimethylarginine in plasma: Methodological considerations and clinical relevance. Clin Chem Lab Med 2005;43:1130-8. (Pubitemid 41581973)
42. Schwedhelm E, Xanthakis V, Maas R, Sullivan LM, Schulze F, Riederer U, et al. Asymmetric dimethylarginine reference intervals determined with liquid chromatography-tandem mass spectrometry: Results from the Framingham offspring cohort. Clin Chem 2009;55:1539-45.